Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral pentavalent rotavirus vaccine (V260) in healthy Chinese infants
CTR20140201Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- May 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rotavirus vaccine, live, oral, pentavalent in rotaviral diarrhea, sponsored by Merck & Co.. Started May 2014; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on CTR20140201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140201.